Automated quality checks and notifications ... Thermo Fisher QuantStudio, Roche Cobas, Agilent Bravo. Collaboration Tools: Slack, Microsoft Teams, and Gmail for instant notifications and task ...

Data from a phase 2 trial of Roche's oral BTK inhibitor fenebrutinib have shown "near-complete suppression" of disease activity and disability progression in relapsing multiple sclerosis (MS).

In amongst a clutch of discontinued phase 3 programmes in Roche's fourth-quarter results update was the news that it has stopped a study of AKT inhibitor ipatasertib as a treatment for first-line ...

Merck's injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech Halozyme Therapeutics , the Wall Street Journal reported on Wednesday, citing ...

Open-source no-code web data extraction platform. Turn websites to APIs & spreadsheets with no-code robots in minutes.